Related Experiment Video

Updated: Jun 5, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010

Christoph Gensch1, Uta Hoppe, Michael Böhm

  • 1Klinik für Innere Medizin III, Kardiologie Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, 66421, Homburg/Saar, Germany. christophgensch@gmx.de

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|December 25, 2010
PubMed

Insights

This review summarizes late-breaking cardiovascular medicine trials presented at the 2010 American Heart Association Congress. Key findings from leading experts offer insights into advancements in cardiovascular research and treatment.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Trials
  • Cardiology

Background:

  • Presents an overview of late-breaking clinical trials in cardiovascular medicine.
  • Focuses on trials presented during the American Heart Association (AHA) Congress in Chicago, November 2010.
  • Summaries are based on oral presentations and webcasts by trial experts.

Purpose of the Study:

  • To provide a comprehensive overview of pivotal late-breaking cardiovascular trials presented at the 2010 AHA Congress.
  • To summarize key data and implications from these trials for the cardiology community.

Main Methods:

  • The article reviews data presented during the hotline sessions of the AHA Congress held in Chicago, November 2010.
  • Information was sourced from oral presentations and webcasts by trial investigators.
  • Trials are discussed in alphabetical order, including ACT, ADVANCE, ASCEND-HF, and others.

Main Results:

  • Summaries cover a range of cardiovascular conditions and interventions.
  • Key findings from trials such as EMPHASIS-HF (heart failure) and ROCKET-AF (atrial fibrillation) are highlighted.
  • The presented data offers insights into new therapeutic approaches and risk stratification.

Conclusions:

  • The reviewed trials represent significant advancements in cardiovascular medicine.
  • These findings are expected to influence clinical practice and future research directions in cardiology.
  • The summaries provide valuable information for clinicians managing cardiovascular diseases.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...